Brookmont Capital Management’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-3,148
Closed -$257K 59
2017
Q1
$257K Hold
3,148
0.1% 54
2016
Q4
$227K Sell
3,148
-7,266
-70% -$525K 0.09% 50
2016
Q3
$809K Buy
10,414
+1,076
+12% +$87K 0.3% 42
2016
Q2
$728K Sell
9,338
-4,479
-32% -$357K 0.27% 43
2016
Q1
$1.13M Sell
13,817
-1,969
-12% -$160K 0.36% 41
2015
Q4
$1.41M Buy
15,786
+1,055
+7% +$89.6K 0.4% 42
2015
Q3
$1.13M Sell
14,731
-290
-2% -$24.2K 0.32% 45
2015
Q2
$1.26M Sell
15,021
-7,470
-33% -$660K 0.32% 45
2015
Q1
$2.03M Buy
22,491
+16,291
+263% +$1.4M 0.51% 44
2014
Q4
$501K Buy
+6,200
New +$490K 0.14% 51

Other funds holding CAH

Brookmont Capital Management's CAH Position: Q2 2017 in Review

Brookmont Capital Management sold out of Cardinal Health (CAH) in Q2 2017, closing a stake of 3,148 shares — an estimated $257K sold.

Brookmont Capital Management first reported a position in CAH in Q4 2014 and held it in 10 quarters. The position peaked at $2.03M in Q1 2015. 747 funds tracked by Wall St. Rank hold CAH as of Q2 2017.

  • Brookmont Capital Management reported no remaining Cardinal Health position as of Q2 2017 after selling out during the quarter.
  • Brookmont Capital Management sold 3,148 Cardinal Health shares in Q2 2017, an estimated $257K.
  • Brookmont Capital Management first reported a position in Cardinal Health in Q4 2014 and held it in 10 quarters.
  • Brookmont Capital Management's Cardinal Health position peaked at $2.03M in Q1 2015.
  • 747 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2017.

Based on Brookmont Capital Management's 13F filing for Q2 2017, filed 11 Aug 2017.